About Cologuard®
and Exact Sciences
The proud sponsors of the Cologuard Classic by Exact Sciences PGA TOUR Champions tournament
Cancer is detected too late
Exact Sciences is changing the way people think about detecting and treating cancer. Their mission is to eradicate cancer through tests that help prevent it, detect it earlier, and guide personalized treatment.
Cancer is detected too late
Exact Sciences is changing the way people think about detecting and treating cancer. Their mission is to eradicate cancer through tests that help prevent it, detect it earlier, and guide personalized treatment.
Expanding colon cancer screening options
In 2014, Exact Sciences launched Cologuard®, an FDA-approved, noninvasive stool-based DNA screening test for adults 45 and older who are at average risk for colon cancer. Since launch, millions have used Cologuard® to screen for colon cancer at home.¹
Expanding colon cancer screening options
In 2014, Exact Sciences launched Cologuard®, an FDA-approved, noninvasive stool-based DNA screening test for adults 45 and older who are at average risk for colon cancer. Since launch, millions have used Cologuard® to screen for colon cancer at home.¹
The ‘most preventable, yet least prevented, cancer'²
Colon cancer affects all races, genders, and ethnicities, and it’s on the rise in people younger than 50.3 An estimated 60M adults in the United States remain unscreened for colon cancer,4,5 which is one reason why it is often caught in later stages when less treatable.6 Screening is vital in detecting cancer early. The Cologuard Classic by Exact Sciences is about so much more than golf. By kicking off National Colorectal Cancer Awareness Month in March, this tournament can help raise awareness of colon cancer, highlight available screening options, and recognize those affected by the disease.
A sought-after
destination
for survivors
In 2023, more than 200 colorectal cancer patients, survivors, loved ones, and advocates attended the tournament from across the country. Exact Sciences proudly provides grants to more than 10 advocacy organizations for patients and survivors to attend the tournament.
For the fourth straight year, all PGA TOUR Champions players are playing on behalf of a survivor or in memory of someone who passed from colon cancer. See this year’s Pairings with a Pro.
If you have been impacted by colorectal cancer and are interested in getting involved with Cologuard Classic, please visit AdvocacyCRC.com to learn more.
If you are interested in supporting even more patients and loved ones attending this event, please consider sponsoring a survivor.
The "most preventable, yet least prevented, cancer"²
Colon cancer affects all races, genders, and ethnicities, and it’s on the rise in people younger than 50.3 An estimated 60M adults in the United States remain unscreened for colon cancer,4,5 which is one reason why it is often caught in later stages when less treatable.6 Screening is vital in detecting cancer early. The Cologuard Classic by Exact Sciences is about so much more than golf. By kicking off National Colorectal Cancer Awareness Month in March, this tournament can help raise awareness of colon cancer, highlight available screening options, and recognize those affected by the disease.
A sought-after destination
for survivors
In 2023, more than 200 colorectal cancer patients, survivors, loved ones, and advocates attended the tournament from across the country. Exact Sciences proudly provides grants to more than 10 advocacy organizations for patients and survivors to attend the tournament.
For the fourth straight year, all PGA TOUR Champions players are playing on behalf of a survivor or in memory of someone who passed from colon cancer. See this year’s Pairings with a Pro.
If you have been impacted by colorectal cancer and are interested in getting involved with Cologuard Classic, please visit AdvocacyCRC.com to learn more.
If you are interested in supporting even more patients and loved ones attending this event, please consider sponsoring a survivor.
Indications and Important Risk Information
Cologuard is intended to screen adults 45 years of age and older who are at average risk for colorectal cancer by detecting certain DNA markers and blood in the stool. Do not use if you have had adenomas, have inflammatory bowel disease and certain hereditary syndromes, or a personal or family history of colorectal cancer. Cologuard is not a replacement for colonoscopy in high risk patients. Cologuard performance in adults ages 45-49 is estimated based on a large clinical study of patients 50 and older. Cologuard performance in repeat testing has not been evaluated.
The Cologuard test result should be interpreted with caution. A positive test result does not confirm the presence of cancer. Patients with a positive test result should be referred for colonoscopy. A negative test result does not confirm the absence of cancer. Patients with a negative test result should discuss with their doctor when they need to be tested again. False positives and false negative results can occur. In a clinical study, 13% of people without cancer received a positive result (false positive) and 8% of people with cancer received a negative result (false negative). Rx only.
*Based on 2022 USA single year census estimates for ages 45-85 inclusive and the percentage of unscreened subjects. Does not account for variable screening rates across age ranges.
References
¹ Internal Data on File. Exact Sciences Corporation. Madison, WI.
² Itzkowitz SH. Incremental advances in excremental cancer detection tests. J Natl Cancer Inst. 2009;101(18):1225- 1227
³ Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average- risk adults: 2018 guidelines update from the American Cancer Society. CA Cancer J Clin. 2018;68(4):250-281
⁴ United States Census Bureau. Annual Estimates of the Resident Population by Single Year of Age and Sex for the United States: April 1, 2020 to July 1, 2022 (NC-EST2022-AGESEX-RES). American Cancer Society. Colorectal Cancer Facts & Figures 2023-2025. Atlanta: American Cancer Society; 2023.
⁵ American Cancer Society. Colorectal Cancer Facts & Figures 2023-2025. Atlanta: American Cancer Society; 2023.
⁶ Siegel RL Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48.
Copyright ©2023 Tucson Conquistadores
Cologuard® is a registered trademark of Exact Sciences Corporation.
